Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Depression Interview Cognitive symptoms in depression Schizophrenia Article Biological basis for adolescence as a window of vulnerability for psychosis Depression Schizophrenia Article Inspiring efforts to improve mental health across countries and ages Migraine Satellite symposium Article Raising the bar for successful migraine prevention